Implications of Cardiopulmonary Risk for the Management of COPD: A Narrative Review Dave SinghMeiLan K. HanChris P. Gale Review Open access 25 April 2024
The Use of Precision Epigenetic Methods for the Diagnosis and Care of Stable Coronary Heart Disease Reduces Healthcare Costs David FrisvoldMeeshanthini DoganRobert Philibert Original Research Open access 25 April 2024
Endovenous Microwave Ablation Versus Laser Ablation for Small Saphenous Vein Varicosis Weiqin LuJinsong JiangGuangwei Yang Original Research 24 April 2024
Stratified Patient Profiling for Vedolizumab Effectiveness in Crohn’s Disease: Identifying Optimal Subgroups for Enhanced Treatment Response in the EVOLVE Study Andres YarurGerassimos J. MantzarisBrian Bressler Original Research Open access 24 April 2024
Development and Application of an Attribute-Based Taxonomy on the Benefits of Oral Anticoagulant Switching in Atrial Fibrillation: A Delphi Study Adenike R. AdelakunMary A. De VeraPeter Loewen Original Research 24 April 2024
Correction to: Association Between Bowel Wall Thickening and Long-Term Outcomes in Decompensated Liver Cirrhosis Xueying WangMin DingXingshun Qi Correction 23 April 2024
Correction to: Psychometric Evaluation of the MENQOL Instrument in Women Experiencing Vasomotor Symptoms Associated with Menopause Neil M. SchultzAntonia MorgaStephanie E. Rhoten Publisher Correction Open access 23 April 2024
Cost-Effectiveness of Recombinant Factor IX Fc Prophylaxis and Recombinant Factor IX On-Demand Treatment in Patients with Haemophilia B Without Inhibitors Michal PochopienAnna TytułaDaniel Eriksson Original Research Open access 23 April 2024
Efgartigimod and Ravulizumab for Treating Acetylcholine Receptor Auto-antibody-Positive (AChR-Ab+) Generalized Myasthenia Gravis: Indirect Treatment Comparison Cécile van SteenLorenzo CelicoSergio Iannazzo Brief Report Open access 20 April 2024
Real-World Data on Therapies for Relapsed or Refractory Multiple Myeloma: Key Data from ASH 2023—A Podcast Luciano J. CostaPaula Rodriguez-Otero Commentary Open access 20 April 2024
Primary Management of Operable Locally Advanced Oral Cavity Squamous Cell Carcinoma: Current Concepts and Strategies Ameya A. AsarkarBrent A. ChangAlfio Ferlito Review 20 April 2024
Rationale and Design of the IMPROVE Trial: A Multicenter, Randomized, Controlled, Open-label, Blinded-endpoint Trial Assessing the Efficacy of Remote Ischemic Conditioning in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting Yang YanChangying ZhaoGuoliang Li Study Protocol 15 April 2024
Reduction in Diabetes-Related Hospitalizations and Medical Costs After Dexcom G6 Continuous Glucose Monitor Initiation in People with Type 2 Diabetes Using Intensive Insulin Therapy Katia L. HannahPoorva M. NemlekarGregory J. Norman Original Research Open access 15 April 2024
Comparative Effectiveness of Valoctocogene Roxaparvovec and Prophylactic Factor VIII Replacement in Severe Hemophilia A Johannes OldenburgHerve ChambostMargareth Ozelo Original Research Open access 15 April 2024
Treatment-Free Interval: A Novel Approach to Assessing Real-World Treatment Effectiveness and Economic Impact Among Patients with Irritable Bowel Syndrome with Diarrhea Brian E. LacyPatrick Gagnon-SanschagrinAnkur A. Dashputre Original Research Open access 15 April 2024
Real-World Effectiveness and Safety of Ramucirumab as a Second-Line Treatment for Patients with Unresectable Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma in Japan and South Korea: A Systematic Literature Review Xiaotian ZhangLi ZhouLin Shen Review Open access 15 April 2024
Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn’s Disease in Italy Melania DovizioSusanne HartzAlessandro Armuzzi Original Research Open access 15 April 2024
Correction to: Real-World Safety and Effectiveness of an 8-Week Regimen of Glecaprevir/Pibrentasvir in Patients with Hepatitis C and Cirrhosis Mei LuLoralee B. RuppStuart C. Gordon Correction Open access 10 April 2024
Exploring the Content Validity of the Unified Wilson Disease Rating Scale: Insights from Qualitative Research Stella KarantzoulisKarli HeuerMegan Teynor Original Research Open access 04 April 2024 Pages: 2070 - 2082
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study Christopher J. PatriquinAndrija BogdanovicJens Panse Original Research Open access 04 April 2024 Pages: 2050 - 2069
Perceptions and Experiences of People with Obesity and Type 2 Diabetes Around Appetite and Eating Behaviors: A Qualitative Study Jiat Ling PoonLouise OHaraBrad Mason Original Research Open access 01 April 2024 Pages: 2028 - 2049
Modelling Treatment Sequences in Immunology: Optimizing Patient Outcomes Rose J. HartFareen HassanDawn Lee Original Research Open access 30 March 2024 Pages: 2010 - 2027
Pharmacological Basis of Differences in Dose Response, Dose Equivalence, and Duration of Action of Inhaled Corticosteroids Peter T. Daley-YatesBhumika AggarwalMaximilian Plank Original Research Open access 27 March 2024 Pages: 1995 - 2009
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis Benjamin ChastekAdam CarreraDavid Staskin Brief Report Open access 23 March 2024 Pages: 2086 - 2097
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine Angela T. H. KwanZiji GuoRoger S. McIntyre Original Research 23 March 2024 Pages: 1983 - 1994
Real-World Outcomes of Individualized Targeted Therapy with Insulin Glargine 300 Units/mL in Insulin-Naïve Korean People with Type 2 Diabetes: TOBE Study Eun-Gyoung HongKyung-Wan MinHak Chul Jang Original Research Open access 21 March 2024 Pages: 1967 - 1982
Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review Mustafa KhasrawPriyanka YalamanchiliEnriqueta Felip Review Open access 21 March 2024 Pages: 1815 - 1842
‘Totality of Evidence’ Approach in the Development of GP2017, an Approved Adalimumab Biosimilar Norman GaylisCharlotte BothPaul Yamauchi Review Open access 21 March 2024 Pages: 1795 - 1814
Enhancing Drug Management, Cost Savings, and Staff Satisfaction in Anesthesiology: A Quality Improvement Project in a Chinese Tertiary Hospital Xiaomin XingHaijun QuFanbo Jing Original Research 18 March 2024 Pages: 1953 - 1966
Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell Lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor Gilles SallesJenny M. H. ChenBijal Shah Original Research Open access 18 March 2024 Pages: 1938 - 1952
Adjusted Indirect Treatment Comparison of Progression-Free Survival with D-Rd and VRd Based on MAIA and SWOG S0777 Individual Patient-Level Data Brian G. M. DurieShaji K. KumarThierry Facon Original Research Open access 18 March 2024 Pages: 1923 - 1937
Correction to: Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis Claire WatkinsTatiana PauloMarloes Bagijn Correction Open access 13 March 2024 Pages: 2084 - 2085
Correction to: The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis Awad AlshahraniNaji KholaifMoeber Mahzari Correction Open access 13 March 2024 Pages: 2083 - 2083
Perioperative and Long-Term Outcomes in Patients Undergoing Synchronous Carotid Endarterectomy and Coronary Artery Bypass Grafting: A Single-Center Experience Paimann NawroziThomas RatschillerAndreas Zierer Original Research Open access 13 March 2024 Pages: 1911 - 1922
Adverse Drug Events Observed with the Newly Approved Remimazolam in Comparison to Propofol for General Anesthesia in Patients Undergoing Surgery: A Meta-analysis Lidan HuangHong LiuSong Tao Original Research 13 March 2024 Pages: 1896 - 1910
Correction to: PRESTO 2: An International Survey to Evaluate Patients’ Injection Experiences with the Latest Devices/Formulations of Long-Acting Somatostatin Analog Therapies for Neuroendocrine Tumors or Acromegaly Dermot O’ToolePamela L. KunzAlly Prebtani Correction 13 March 2024
Comparison of Healthcare Costs for Women with Treated Versus Untreated Vasomotor Symptoms Due to Menopause Aki ShiozawaShayna MancusoHelen M. Trenz Original Research Open access 11 March 2024 Pages: 1885 - 1895
The Humanistic and Economic Burden Associated with Major Depressive Disorder: A Retrospective Cross-Sectional Analysis Larry CulpepperAshley MartinMousam Parikh Original Research Open access 11 March 2024 Pages: 1860 - 1884
Relevance of Adalimumab Product Attributes to Patient Experience in the Biosimilar Era: A Narrative Review Jessica R. AllegrettiJessica H. BradyAlvin Wells Review Open access 11 March 2024 Pages: 1775 - 1794
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study Motohiro OzoneSusumu HirotaNaohisa Uchimura Original Research Open access 09 March 2024 Pages: 1728 - 1745
Incidence and Costs of Clinically Significant Events with Systemic Therapy in Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Cohort Study Daniel J. SimmonsStephen J. ValerioJanvi Sah Original Research Open access 05 March 2024 Pages: 1711 - 1727
Increased Nasal Blimp1 + Treg Cells After Sublingual Immunotherapy Reflect the Efficacy of Treatment in Allergic Rhinitis Yue PanXinxin ZhangLei Cheng Original Research 05 March 2024 Pages: 1698 - 1710
Left Atrial Strain Insights in Atrial Fibrillation and the Interplay with Metabolic Syndrome Hyun-Jin KimHyun-Sun Kim Original Research 05 March 2024 Pages: 1685 - 1697
Satisfaction with the Injection Experience of a New, Citrate-Free Formulation of Ixekizumab Sanjay ChabraJulie BirtW. Chad Cragun Original Research Open access 05 March 2024 Pages: 1672 - 1684
An Update on Stiripentol Mechanisms of Action: A Narrative Review Alexandre BacqAntoine DepaulisMarc Verleye Review Open access 05 March 2024 Pages: 1351 - 1371
Patient and Clinician Perspectives: To Create a Better Future for Chronic Kidney Disease, We Need to Talk About Our Kidneys Pamela R. KushnerJane DeMeisNavdeep Tangri Commentary Open access 05 March 2024 Pages: 1318 - 1324
Study Design of a Phase 2/3 Randomized Controlled Trial of Dupilumab in Adults with Bullous Pemphigoid: LIBERTY-BP ADEPT Dédée F. MurrellPascal JolyArsalan Shabbir Study Protocol Open access 05 March 2024
Correction to: Association of Patient Satisfaction with Cataract Grading in Five Types of Multifocal IOLs Sana NiaziZisis GatzioufasFarideh Doroodgar Correction 02 March 2024 Pages: 1774 - 1774
Treatment Patterns with Mirabegron and Antimuscarinics for Overactive Bladder: A Prospective, Registry Study in Taiwan and South Korea (FAITH) Seung-June OhSung Tae ChoBudiwan Sumarsono Original Research Open access 02 March 2024 Pages: 1652 - 1671
Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies Nandita KheraMarie Louise EdwardsUsama Gergis Original Research Open access 01 March 2024 Pages: 1637 - 1651